Total trials
224
Active
28
Phase 3
5
Total enrollment
495,278
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Acellular Dermal Matrix | — | — | — | — | — | 1 | |
| 1000 ppm F toothpaste | — | — | — | — | — | 1 | |
| Anesthetic spray | — | — | — | — | — | 1 | |
| Masking Tape | — | — | — | — | — | 1 | |
| d-PTFE | — | — | — | — | — | 1 | |
| Ti-mesh | — | — | — | — | — | 1 |
Next readouts
- 2018-03
- 2025-09
- 2027-12-01
- 2027-12-07
Top conditions
- Obesity12
- Cardiovascular Diseases11
- Healthy9
- Sarcopenia9
- Heart Diseases7
- Cardiovascular Disease6
- Telehealth6
- Dietary Intake6
Frequently asked questions about Tufts University
- How many clinical trials does Tufts University have on ClinicalTrials.gov?
- Tufts University is listed as the lead sponsor on 224 clinical trials in ClinicalTrials.gov, 28 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Tufts University's trials are in Phase 3?
- 5 of Tufts University's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Tufts University focus on?
- Tufts University's most-studied conditions on ClinicalTrials.gov are Obesity, Cardiovascular Diseases, Healthy, Sarcopenia, Heart Diseases.
- When are Tufts University's next clinical trial readouts?
- Tufts University has 4 upcoming primary-completion readouts tracked here; the soonest is “Comparing the Efficacy and Morbidity of Two Vertical Ridge Augmentation Techniques”, expected around 2018-03.